Загрузка...
Circulating biomarkers to monitor cancer progression and treatment
Tumor heterogeneity is a major challenge and the root cause of resistance to treatment. Still, the standard diagnostic approach relies on the analysis of a single tumor sample from a local or metastatic site that is obtained at a given time point. Due to intratumoral heterogeneity and selection of s...
Сохранить в:
| Опубликовано в: : | Comput Struct Biotechnol J |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Research Network of Computational and Structural Biotechnology
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913179/ https://ncbi.nlm.nih.gov/pubmed/27358717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2016.05.004 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|